BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1307 related articles for article (PubMed ID: 24248382)

  • 1. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia.
    Zu T; Liu Y; Bañez-Coronel M; Reid T; Pletnikova O; Lewis J; Miller TM; Harms MB; Falchook AE; Subramony SH; Ostrow LW; Rothstein JD; Troncoso JC; Ranum LP
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):E4968-77. PubMed ID: 24248382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS.
    Gendron TF; Bieniek KF; Zhang YJ; Jansen-West K; Ash PE; Caulfield T; Daughrity L; Dunmore JH; Castanedes-Casey M; Chew J; Cosio DM; van Blitterswijk M; Lee WC; Rademakers R; Boylan KB; Dickson DW; Petrucelli L
    Acta Neuropathol; 2013 Dec; 126(6):829-44. PubMed ID: 24129584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model.
    Nguyen L; Montrasio F; Pattamatta A; Tusi SK; Bardhi O; Meyer KD; Hayes L; Nakamura K; Banez-Coronel M; Coyne A; Guo S; Laboissonniere LA; Gu Y; Narayanan S; Smith B; Nitsch RM; Kankel MW; Rushe M; Rothstein J; Zu T; Grimm J; Ranum LPW
    Neuron; 2020 Feb; 105(4):645-662.e11. PubMed ID: 31831332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
    Wen X; Westergard T; Pasinelli P; Trotti D
    Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention.
    Donnelly CJ; Zhang PW; Pham JT; Haeusler AR; Mistry NA; Vidensky S; Daley EL; Poth EM; Hoover B; Fines DM; Maragakis N; Tienari PJ; Petrucelli L; Traynor BJ; Wang J; Rigo F; Bennett CF; Blackshaw S; Sattler R; Rothstein JD
    Neuron; 2013 Oct; 80(2):415-28. PubMed ID: 24139042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease Mechanisms of
    Gendron TF; Petrucelli L
    Cold Spring Harb Perspect Med; 2018 Apr; 8(4):. PubMed ID: 28130314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice.
    Peters OM; Cabrera GT; Tran H; Gendron TF; McKeon JE; Metterville J; Weiss A; Wightman N; Salameh J; Kim J; Sun H; Boylan KB; Dickson D; Kennedy Z; Lin Z; Zhang YJ; Daughrity L; Jung C; Gao FB; Sapp PC; Horvitz HR; Bosco DA; Brown SP; de Jong P; Petrucelli L; Mueller C; Brown RH
    Neuron; 2015 Dec; 88(5):902-909. PubMed ID: 26637797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS.
    Gitler AD; Tsuiji H
    Brain Res; 2016 Sep; 1647():19-29. PubMed ID: 27059391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sense and antisense RNA are not toxic in Drosophila models of C9orf72-associated ALS/FTD.
    Moens TG; Mizielinska S; Niccoli T; Mitchell JS; Thoeng A; Ridler CE; Grönke S; Esser J; Heslegrave A; Zetterberg H; Partridge L; Isaacs AM
    Acta Neuropathol; 2018 Mar; 135(3):445-457. PubMed ID: 29380049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3.
    Ramesh N; Daley EL; Gleixner AM; Mann JR; Kour S; Mawrie D; Anderson EN; Kofler J; Donnelly CJ; Kiskinis E; Pandey UB
    Acta Neuropathol Commun; 2020 Oct; 8(1):177. PubMed ID: 33129345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia.
    Stepto A; Gallo JM; Shaw CE; Hirth F
    Acta Neuropathol; 2014 Mar; 127(3):377-89. PubMed ID: 24366528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All in the Family: Repeats and ALS/FTD.
    Pattamatta A; Cleary JD; Ranum LPW
    Trends Neurosci; 2018 May; 41(5):247-250. PubMed ID: 29703376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress.
    Zhang YJ; Jansen-West K; Xu YF; Gendron TF; Bieniek KF; Lin WL; Sasaguri H; Caulfield T; Hubbard J; Daughrity L; Chew J; Belzil VV; Prudencio M; Stankowski JN; Castanedes-Casey M; Whitelaw E; Ash PE; DeTure M; Rademakers R; Boylan KB; Dickson DW; Petrucelli L
    Acta Neuropathol; 2014 Oct; 128(4):505-24. PubMed ID: 25173361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention of hexanucleotide repeat-containing intron in C9orf72 mRNA: implications for the pathogenesis of ALS/FTD.
    Niblock M; Smith BN; Lee YB; Sardone V; Topp S; Troakes C; Al-Sarraj S; Leblond CS; Dion PA; Rouleau GA; Shaw CE; Gallo JM
    Acta Neuropathol Commun; 2016 Feb; 4():18. PubMed ID: 26916632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
    Starr A; Sattler R
    Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.
    Beckers J; Tharkeshwar AK; Van Damme P
    Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model.
    Zhang K; Wang A; Zhong K; Qi S; Wei C; Shu X; Tu WY; Xu W; Xia C; Xiao Y; Chen A; Bai L; Zhang J; Luo B; Wang W; Shen C
    Neuron; 2021 Jun; 109(12):1949-1962.e6. PubMed ID: 33991504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers.
    Mackenzie IR; Frick P; Grässer FA; Gendron TF; Petrucelli L; Cashman NR; Edbauer D; Kremmer E; Prudlo J; Troost D; Neumann M
    Acta Neuropathol; 2015 Dec; 130(6):845-61. PubMed ID: 26374446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD.
    O'Rourke JG; Bogdanik L; Muhammad AKMG; Gendron TF; Kim KJ; Austin A; Cady J; Liu EY; Zarrow J; Grant S; Ho R; Bell S; Carmona S; Simpkinson M; Lall D; Wu K; Daughrity L; Dickson DW; Harms MB; Petrucelli L; Lee EB; Lutz CM; Baloh RH
    Neuron; 2015 Dec; 88(5):892-901. PubMed ID: 26637796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy.
    Cooper-Knock J; Higginbottom A; Stopford MJ; Highley JR; Ince PG; Wharton SB; Pickering-Brown S; Kirby J; Hautbergue GM; Shaw PJ
    Acta Neuropathol; 2015 Jul; 130(1):63-75. PubMed ID: 25943887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.